cycle help

**dirty bird** · 01-09-2004, 09:00 AM

just wanted some feedback on a cycle i wnated to start in a few weeks. my stats are 6'2. 235 lbs. this is my third cycle. i wnated to bulk up a little more.

sustanol 250 - weeks 1-12 - 500 mg wk
deca - weeks 1 -12 - 400 mg wk
fina - weeks 7 -15 7m ED

i have nolvadex on hand. i have clomid also. just wasn't sure when to start. any help would be greatly appreciated.

dirty bird

**scottninpo** · 01-09-2004, 09:02 AM

tren makes recovery difficult, so you'll want to run the test past the tren by two weeks

***Pheedno*** · 01-09-2004, 09:17 AM

Originally Posted by dirty bird

just wanted some feedback on a cycle i wnated to start in a few weeks. my stats are 6'2. 235 lbs. this is my third cycle. i wnated to bulk up a little more.

sustanol 250 - weeks 1-12 - 500 mg wk
deca - weeks 1 -12 - 400 mg wk
fina - weeks 7 -15 7m ED

i have nolvadex on hand. i have clomid also. just wasn't sure when to start. any help would be greatly appreciated.

dirty bird

Run your tren wks4-12 for recovery reasons, as scott stated

Also, is your going to run Deca and tren in the same cycle, use an AI and nolva throughout
.25mg L-dex + 10mg Nolva

Start Nolva/Clomid/L-dex for PCT 3wks after last Sust/Deca injection

**scottninpo** · 01-09-2004, 09:18 AM

pheedno, i thought by running ldex through pct would keep estrogen levels too low, hurting recovery?

**dirty bird** · 01-09-2004, 09:54 AM

would it be better to drop the deca and use d-bol instead?

***Pheedno*** · 01-09-2004, 09:58 AM

Originally Posted by scottninpo

pheedno, i thought by running ldex through pct would keep estrogen levels too low, hurting recovery?

Aromatase inhibitors in men

The effect of aromatase inhibition on male gonadotrophin and sex steroid concentrations is illustrated in the paper by Trunet et al. (1993): 2.5 mg letrozole suppressed plasma oestradiol concentrations to less than 50% of pretreatment after 2 days, with recovery to approximately pretreatment values after 6 days. These decreases were accompanied by increased gonadotrophin concentrations, with resultant increases of approximately 50% in plasma testosterone . These results, and those previously published (Bhatnagar et al. 1992) on the effects of fadrozole in men, indicate that the aromatization pathway is of major importance in the regulation of gonodotrophin secretion by aromatically androgens